Top

News

Al-Shifa Trust and Anhui Zhifei Longcom Biopharmaceutical Co. Ltd. have signed an agreement to initiate phase III clinical trials of COVID-19 vaccine

Al-Shifa Trust and Anhui Zhifei Longcom Biopharmaceutical Co. Ltd. have signed an agreement to initiate phase III clinical trials of COVID-19 vaccine, ZF2001 in Al-Shifa Trust Eye Hospital, Rawalpindi. The vaccine has been approved by the Drug Regulatory Authority of Pakistan (DRAP) and trials will be conducted in five territories of Pakistan. The trials have begun from April 5, 2021.